Document is current
Any future updates will be listed below
-
Authors
Ying, Zhitao
He, Ting
Wang, Xiaopei
Zheng, Wen
Lin, Ningjing
Tu, Meifeng
Xie, Yan
Ping, Lingyan
Zhang, Chen
Liu, Weiping
Deng, Lijuan
Wu, Meng
Feng, Feier
Leng, Xin
Du, Tingting
Qi, Feifei
Hu, Xuelian
Ding, Yanping
Lu, Xin-an http://orcid.org/0000-0003-4721-1684
Song, Yuqin
Zhu, Jun
-
Funding
Funding for this research was provided by:
Beijing Natural Science Foundation (7202025,7202026)
Capital’s Funds for Health Improvement and Research (2018-1-2151,2020-2Z-2157)
Science Foundation of Peking University Cancer Hospital (2020-5)
National Natural Science Foundation of China (81870154,81972807,81670187,81970179,81700197)
Beijing Municipal Science & Technology Commission (Z181100001918019)
Beijing Municipal Administration of Hospitals' Ascent Plan (DFL20151001)
Open Project funded by Key laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing (2019 Open Project-08)
Beijing Xisike Clinical Oncology Research Foundation (Y-Young2020-0524)
- License Information
-
More Information
Article History
Received: 30 August 2020
Accepted: 18 February 2021
First Online: 25 February 2021
Ethics approval and consent to participate
: The animal study was approved by the Tsinghua University Animal Care and Use Committee (Beijing, China). The clinical study was approved by the Ethics Committee of Drug Clinical Trials of Peking University Cancer Hospital. This study was conducted in accordance with the Declaration of Helsinki, and all participants were informed of the possible risks and side effects of the therapy, and provided signed informed consent.
: Not Applicable.
: The authors declare that they have no competing interests.
